| Project/Area Number |
06670580
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Jichi Medical School |
|---|
Principal Investigator |
MORIYAMA Takashi Jichi Medical School, Liver Study Laboratory, Assistant Professor, 医学部, 講師 (10240706)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
ANDO Kazuki Jichi Medical School, Liver Study Laboratory, Assistant, 医学部, 助手 (20265276)
KANEKO Takashi Jichi Medical School, Liver Study Laboratory, Assistant, 医学部, 助手 (10254913)
|
|---|
| Project Period (FY) |
1994 – 1995
|
| Project Status |
Completed (Fiscal Year 1995)
|
| Budget Amount *help |
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1995: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1994: ¥1,100,000 (Direct Cost: ¥1,100,000)
|
|---|
| Keywords | HCV core protein / Cytotoxic T lymphocytes / DNA immunization |
|---|
| Research Abstract |
Basic strategy for prevention of viral infection is, in general, to induce neutralizing antibody. This strategey, however, may not apply to hepatitis C,because there is no known neutralizing antibody that leads to the termination of infection. Cytotoxic T lymphocytes (CTL) also eradicates viral infection. Methods of inducing CTL is not as well established as those of inducing antibodies. A new method of inducing CTL is to use a naked DNA coding target antigens as an immunogen. The objective of this study is to test whether this technology is applicable to hepatitis C virus.
Mice were immunized with cDNA coding hepatitis C core region intramuscularly. Primed splenocytes showed a hepatitis C core protein specific proliferation. The splenocytes were also cultured with a cell line that expressed hepatitis C core protein. Cultured splenocytes showed specific CTL responses to hepatitis C core.
These results suggest that the DNA immunization method is applicable to hepatitis C virus antigens. For further analysis, transgenic mouse systems that express hepatitis C virus antigens at a higher level are under construction.
|
